By Natasha Roberts
Date: Tuesday 22 Apr 2014
LONDON (ShareCast) - AIM-listed natural micro-encapsulation company, Eden Research, on Tuesday announced that its licensee, TerpeneTech, has launched two pet odour neutralising products for companion animals in France.
Both products make use of Eden's encapsulation technology, marking the first-ever commercial launch of products using Eden's intellectual property (IP) in encapsulation.
The two products, YP Odor Control Formula and YP Odor Control Seborrhea, will initially be distributed in France by Laboratoires Agecom under its E Lotion brand before being distributed in other territories around the world. Both products are natural products that neutralise bad odours on dogs and cats.
TerpeneTech has a licence agreement with Eden for the use of Eden's patented encapsulation technology in consumer and agricultural related biocides. Under the agreement, Eden will receive royalty income on the net sales of the product on an ongoing basis.
Clive Newitt, the Managing Director of Eden, said: "The first commercial launch of products using our IP is a key milestone for the company and introduces the first stream of royalty revenues to the company.
"The strategy of licensing our technology and receiving a royalty on product sales allows Eden to benefit from the development and commercialisation of these products by companies who have expertise in their particular market sector. We expect to see further revenues generated through royalties as more of our licensees bring their products to market in the near future."
NR
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 4.20p |
Change Today | 0.050p |
% Change | 1.20 % |
52 Week High | 11.85p |
52 Week Low | 3.82p |
Volume | 1,526,850 |
Shares Issued | 533.35m |
Market Cap | £22.40m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:59 | 596,915 @ 4.40p |
15:05 | 459,563 @ 4.35p |
14:52 | 7,933 @ 4.08p |
14:46 | 12,737 @ 4.08p |
14:37 | 13,833 @ 3.82p |
CFO | Alexander John Abrey |
CEO | Sean M. Smith |
You are here: research